CN Stock MarketDetailed Quotes

688177 Bio-Thera Solutions,

Watchlist
  • 22.30
  • -0.02-0.09%
Market Closed Apr 30 15:00 CST
9.23BMarket Cap-19.06P/E (TTM)

About Bio-Thera Solutions, Company

The company was officially listed and traded on the Science and Technology Innovation Board of the Shanghai Stock Exchange in February 2020. Under the leadership of the company's technical management team, it has successfully broken through a series of key technologies and established a rich product pipeline in the fields of oncology, autoimmune diseases, cardiovascular diseases, ophthalmology, etc. The company is an innovative biopharmaceutical enterprise with research and development of innovative drugs and biosimilar drugs as the core. Its main business is drug R&D, production and sales, and it has an independent and complete R&D, procurement, production and commercialization system. Major products: Galeride, Prerich, Schrelli, and Betanin. Corporate honors: Guangdong Antibody Drug Coupling Biomedical Engineering Laboratory (Guangdong Engineering Laboratory), Guangdong PhD Workstation, R&D facility construction of Baiaotai Biotechnology (Guangzhou) Co., Ltd., “Most Promising Company” for venture capital in Hong Kong, etc.

Company Profile

Short Name-A百奥泰生物
Company NameBio-Thera Solutions, Ltd.
Listing DateFeb 21, 2020
Issue Price32.76
Shares Offered60.00M share(s)
FoundedJul 28, 2003
Chairmanshengfeng li
Legal Representativeshengfeng li
General Managershengfeng li
Secretarydan yu
Employees1251
ProvinceGuang Dong Sheng
Phone8620-32203528
Office Address5th Floor, Building A6, No. 11, Kaiyuan Avenue, Science City, Guangzhou High-tech Industrial Development Zone
Zip Code510530
Registered Address5th Floor, Building A6, No. 11, Kaiyuan Avenue, Science City, Guangzhou High-tech Industrial Development Zone, Guangdong
Fax8620-32203218
EmailIR@bio-thera.com
Business License91440116751954446J
BusinessThe issuer was founded as an innovative biopharmaceutical company with research and development of innovative drugs and biosimilar drugs as the core.

Company Executives

  • Name
  • Position
  • Salary
  • xianming huang
  • Executive Director
  • 2.18M
  • shengfeng li
  • Executive Director, General Manager, Core Technical Personnel
  • 2.41M
  • jinquan yu
  • Executive Director, Deputy General Manager, Core Technical Personnel
  • 2.52M
  • jun qiu
  • Non-executive Directors
  • --
  • dan yu
  • Executive Director, Board Secretary
  • 924.90K
  • hengli wei
  • Independent Directors
  • --
  • jianping wang
  • Independent Non-Executive Director
  • --
  • dehan huang
  • Independent Directors
  • 120.00K
  • shanshan song
  • Securities Affairs Representative
  • --
  • xiaoyun wu
  • Chairman of the Supervisory Board, Auditors, Core Technical Personnel
  • 890.20K
  • weijia tang
  • Auditors, Core Technical Personnel
  • 697.30K
  • xianhong zhan
  • Chief Financial Officer
  • 852.50K
  • fan li
  • Head of Internal Audit
  • --
  • cai bao
  • Core Technical Personnel
  • 1.44M
  • yifan chen
  • Employee Supervisors
  • 615.80K

Market Insights

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. Do you think Buffett was scooping up stocks during the recent dip? 2. In the face of market changes, do you prefer to stick Show More